Blauvelt, A. , Conrad, C. , Costanzo, A. , van de Kerkhof, P. , Han, G. , Langley, R.G. , Davis, L. , Hoepken, B. , Wiegratz, S. and Puig, L. 2024. Bimekizumab Continuous Maintenance of Eesponse at Every Visit Through Two Years in Patients with Moderate to Severe Plaque Psoriasis: Post-hoc Results from Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s303. DOI:https://doi.org/10.25251/skin.8.supp.303.